{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T13:52:40Z","timestamp":1793627560994,"version":"4.5.1"},"reference-count":15,"publisher":"Editorial Committee of Japanese Journal of Infectious Diseases, National Institute of Infectious Dis","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Jpn J Infect Dis"],"published-print":{"date-parts":[[2022,7,31]]},"DOI":"10.7883\/yoken.jjid.2021.796","type":"journal-article","created":{"date-parts":[[2022,2,27]],"date-time":"2022-02-27T22:08:22Z","timestamp":1645999702000},"page":"423-426","source":"Crossref","is-referenced-by-count":37,"title":["A Patient with Severe Fever with Thrombocytopenia Syndrome (SFTS) Infected from a Sick Dog with SFTS Virus Infection"],"prefix":"10.7883","volume":"75","author":[{"given":"Hiroaki","family":"Oshima","sequence":"first","affiliation":[{"name":"Oshima Animal Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hironobu","family":"Okumura","sequence":"additional","affiliation":[{"name":"Clinic Okumura, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Maeda","sequence":"additional","affiliation":[{"name":"Laboratory of Veterinary Microbiology, Joint Faculty of Veterinary Medicine, Yamaguchi University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keita","family":"Ishijima","sequence":"additional","affiliation":[{"name":"Laboratory of Veterinary Microbiology, Joint Faculty of Veterinary Medicine, Yamaguchi University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoki","family":"Yoshikawa","sequence":"additional","affiliation":[{"name":"Department of Virology I, National Institute of Infectious Diseases, Murayama Branch, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Kurosu","sequence":"additional","affiliation":[{"name":"Department of Virology I, National Institute of Infectious Diseases, Murayama Branch, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuetsu","family":"Fukushi","sequence":"additional","affiliation":[{"name":"Department of Virology I, National Institute of Infectious Diseases, Murayama Branch, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Shimojima","sequence":"additional","affiliation":[{"name":"Department of Virology I, National Institute of Infectious Diseases, Murayama Branch, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Saijo","sequence":"additional","affiliation":[{"name":"Department of Virology I, National Institute of Infectious Diseases, Murayama Branch, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4631","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Yu XJ, Liang MF, Zhang SY, et al. Fever with thrombocytopenia associated with a novel bunyavirus in China. N Engl J Med. 2011;364:1523-1532.","DOI":"10.1056\/NEJMoa1010095"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Takahashi T, Maeda K, Suzuki T, et al. The first identification and retrospective study of severe fever with thrombocytopenia syndrome in Japan. J Infect Dis. 2014;209:816-827.","DOI":"10.1093\/infdis\/jit603"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Kim KH, Yi J, Kim G, et al. Severe fever with thrombocytopenia syndrome, South Korea, 2012. Emerg Infect Dis. 2013;19:1892-1894.","DOI":"10.3201\/eid1911.130792"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Yoshikawa T, Fukushi S, Tani H, et al. Sensitive and specific PCR systems for detection of both Chinese and Japanese severe fever with thrombocytopenia syndrome virus strains and prediction of patient survival based on viral load. J Clin Microbiol. 2014;52:3325-3333.","DOI":"10.1128\/JCM.00742-14"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Fukuma A, Fukushi S, Yoshikawa T, et al. Severe fever with thrombocytopenia syndrome virus antigen detection using monoclonal antibodies to the nucleocapsid protein. PLoS Negl Trop Dis. 2016;10:e0004595.","DOI":"10.1371\/journal.pntd.0004595"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Yoshikawa T, Shimojima M, Fukushi S, et al. Phylogenetic and geographic relationships of severe fever with thrombocytopenia syndrome virus in China, South Korea, and Japan. J Infect Dis. 2015;212:889-898.","DOI":"10.1093\/infdis\/jiv144"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Kobayashi Y, Kato H, Yamagishi T, et al. Severe fever with thrombocytopenia syndrome, Japan, 2013\u20132017. Emerg Infect Dis. 2020;26(4:692-9.","DOI":"10.3201\/eid2604.191011"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Kimura T, Fukuma A, Shimojima M, et al. Seroprevalence of severe fever with thrombocytopenia syndrome (SFTS) virus antibodies in humans and animals in Ehime prefecture, Japan, an endemic region of SFTS. J Infect Chemother. 2018;24:802-806.","DOI":"10.1016\/j.jiac.2018.06.007"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Gokuden M, Fukushi S, Saijo M, et al. Low seroprevalence of severe fever with thrombocytopenia syndrome virus antibodies in individuals living in an endemic area in Japan. Jpn J Infect Dis. 2018;71:225-228.","DOI":"10.7883\/yoken.JJID.2017.497"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Park ES, Fujita O, Kimura M, et al. Diagnostic system for the detection of severe fever with thrombocytopenia syndrome virus RNA from suspected infected animals. PLoS One. 2021;16:e0238671.","DOI":"10.1371\/journal.pone.0238671"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Park ES, Shimojima M, Nagata N, et al. Severe fever with thrombocytopenia syndrome phlebovirus causes lethal viral hemorrhagic fever in cats. Sci Rep. 2019;9:11990.","DOI":"10.1038\/s41598-019-48317-8"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Saijo M. Pathophysiology of severe fever with thrombocytopenia syndrome and development of specific antiviral therapy. J Infect Chemother 2018;24:773-781.","DOI":"10.1016\/j.jiac.2018.07.009"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Yuan Y, Lu QB, Yao WS, et al. Clinical efficacy and safety evaluation of favipiravir in treating patients with severe fever with thrombocytopenia syndrome. EBioMedicine. 2021;72:103591.","DOI":"10.1016\/j.ebiom.2021.103591"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Suemori K, Saijo M, Yamanaka A, et al. A multicenter non-randomized, uncontrolled single arm trial for evaluation of the efficacy and the safety of the treatment with favipiravir for patients with severe fever with thrombocytopenia syndrome. PLoS Negl Trop Dis. 2021;15:e0009103.","DOI":"10.1371\/journal.pntd.0009103"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Li H, Jiang XM, Cui N, et al. Clinical effect and antiviral mechanism of T-705 in treating severe fever with thrombocytopenia syndrome. Signal Transduct Target Ther. 2021;6:145.","DOI":"10.1038\/s41392-021-00541-3"}],"container-title":["Japanese Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/yoken\/75\/4\/75_JJID.2021.796\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,23]],"date-time":"2022-07-23T04:38:12Z","timestamp":1658551092000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/yoken\/75\/4\/75_JJID.2021.796\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,31]]},"references-count":15,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.7883\/yoken.jjid.2021.796","relation":{},"ISSN":["1344-6304","1884-2836"],"issn-type":[{"value":"1344-6304","type":"print"},{"value":"1884-2836","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,31]]},"article-number":"JJID.2021.796"}}